By Michele Maatouk
Date: Tuesday 19 Mar 2024
LONDON (ShareCast) - (Sharecast News) - Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
Pfizer was planning to sell around 630m shares in a public offering but the size of the offering was increased to just over 790.5m.
Haleon sold 594m ordinary shares at £3.08 each and 196.5m American Depository Shares (ADR) at $7.85 each. It raised around £1.8bn and $1.5bn, respectively.
The maker of Sensodyne toothpaste and Panadol said it has also agreed to buy back 102.2m ordinary shares from Pfizer off-market for around £315m.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 329.90p |
Change Today | 1.30p |
% Change | 0.40 % |
52 Week High | 346.55 |
52 Week Low | 308.55 |
Volume | 31,717,296 |
Shares Issued | 9,132m |
Market Cap | £30,128m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 14-Mar-24 | 24-Aug-23 |
Paid | 16-May-24 | 05-Oct-23 |
Amount | 4.20p | 1.80p |
Time | Volume / Share Price |
16:35 | 1,359,008 @ 329.46p |
16:35 | 766,824 @ 329.46p |
16:35 | 5,998,715 @ 329.90p |
16:35 | 947 @ 329.90p |
16:35 | 4,260 @ 329.90p |
CFO | Tobias Hestler |
CEO | Brian McNamara |
CEO | Deirdre Mahlan |
You are here: research